In this episode, Katharine Barnard-Kelly, PhD, Chartered Health Psychologist, joins me to discuss the critical intersection of mental health, chronic disease management, and medtech innovation. Dr. Barnard-Kelly has spent her career measuring the psychosocial impact of disease and translating that research into tangible tools for clinicians and regulators alike.
As the co-founder and CEO of Spotlight-AQ, an AI-driven patient engagement platform, she shares how her technology is revolutionizing healthcare—reducing clinician burnout, improving diabetes management, and ensuring that patient voices are truly heard in medical decision-making.
00:00 Introduction to MedTech Innovation
00:49 Meet Dr. Katharine Barnard-Kelly
02:46 Early Career and Academic Journey
06:30 Discovering Diabetes and Quality of Life Research
08:57 Challenges in Diabetes Management
14:36 Advancements in Insulin Pump Therapy
19:35 The Importance of Psychosocial Outcomes
26:28 Developing the Inspire Measurement Tool
36:22 INSPIRE Measures and FDA Interest
37:44 Standardizing Person-Reported Outcomes
39:50 Spotlight-AQ: Revolutionizing Routine Care
41:49 AI-Driven Pre-Clinic Assessments
43:39 Expanding Spotlight-AQ to Other Conditions
51:15 Addressing Clinician Burnout
55:56 Future of Spotlight-AQ and Healthcare
01:07:39 Personal and Professional Next Steps
01:11:11 Conclusion and Final Thoughts
Follow Shannon and Katharine:
Connect with Shannon:
LinkedIn: https://www.linkedin.com/in/shannonlantzy
Website: https://www.shannonlantzy.com/
Connect with Katharine:
LinkedIn: https://www.linkedin.com/in/katharine-barnard-kelly-phd-0a14b032/
Website: https://www.spotlight-aq.com/
